Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina.
BACKGROUND
C-reactive protein (CRP) plasma levels have been associated with short- and long-term occurrence of coronary events. We investigated whether circulating inflammatory cell responsiveness to low-grade stimuli could contribute to the reported association between CRP and coronary events.


RESULTS
We studied 32 patients with unstable angina who were followed for 24 months and were free of symptoms for 6 months (group 1): 19 patients had persistently high CRP levels (>0.3 mg/dL) (group 1A); 13 patients had normal CRP levels (group 1B). During the follow-up, 12 (63%) group 1A but no group 1B patients developed an infarction or recurrence of unstable angina (P<0.001). Eighteen patients with chronic stable angina (group 2) and 18 healthy subjects (group 3) were studied as controls. Interleukin (IL)-6 production (median, range) by peripheral blood mononuclear cells after 4 hours of in vitro stimulation with 1 ng/mL lipopolysaccharide (LPS) was significantly higher in group 1A (4526 pg/mL, 3042 to 10 583 pg/mL) than in group 1B (1752 pg/mL, 75 to 3981 pg/mL), group 2 (707 pg/mL, 41 to 3275 pg/mL), and group 3 (488 pg/mL, 92 to 3503 pg/mL) (all P<0.001). No significant differences were observed among the other groups. IL-6 production after LPS-challenge was correlated with baseline CRP levels (r=0.42, P=0.005).


CONCLUSIONS
Mononuclear cells of patients with recurrent phases of instability exhibit an enhanced production of IL-6 in response to low-dose of LPS, correlated with baseline CRP levels, 6 months after the last acute event. This persisting enhanced acute-phase responsiveness may help explain the association between CRP and acute coronary events.
Liuzzo
G
G
Department of Cardiology, Catholic University, Rome, Italy. gliuzzo@hotmail.com
Angiolillo
D J
DJ
Buffon
A
A
Rizzello
V
V
Colizzi
C
C
Ginnetti
F
F
Biasucci
L M
LM
Maseri
A
A
D000789:Angina, Unstable / Q000175:diagnosis* / Q000276:immunology* / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism / Q000494:pharmacology; D002469:Cell Separation; D002908:Chronic Disease; D004357:Drug Synergism; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis / Q000097:blood; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology* / Q000378:metabolism; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012008:Recurrence
D015850:Interleukin-6; D008070:Lipopolysaccharides; D002097:C-Reactive Protein